BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Drug Development

  Alnylam Pharmaceuticals Presents New Pre-Clinical Data on ALN-TTR, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis

  November 2, 2009

   · 

  1 min read
• FDA

  Kinetic Concepts, Inc. Announces Final Approval to Enter Japan Market

  November 2, 2009

   · 

  1 min read
• Business

  ICON Selected by Eli Lilly and Company to Oversee its Clinical Data Management in Japan

  November 2, 2009

   · 

  1 min read
• Drug Development

  Bristol-Myers Squibb Company and ZymoGenetics, Inc. Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C

  November 2, 2009

   · 

  1 min read
• Pharm Country

  Partnerships in Clinical Trials Expands Its Global Reach

  November 2, 2009

   · 

  1 min read
• Genetown

  Phase Forward to Host Eighth Annual International Users Conference, November 3-5, Boston

  November 2, 2009

   · 

  1 min read
• Drug Development

  Seaside Therapeutics Initiates Clinical Development of Novel Treatment for Fragile X Syndrome

  November 2, 2009

   · 

  1 min read
• BioMidwest

  Smiths Medical, Inc.'s Medfusion(R) 3500 Syringe Pump Now Recognizes Enteral Syringes, Reducing the Potential Risk of Dangerous IV / Enteral Misconnections

  November 2, 2009

   · 

  1 min read
• Drug Development

  Juvaris BioTherapeutics Initiates Phase 2 Study of Influenza Vaccine Adjuvant in Elderly Population

  November 2, 2009

   · 

  1 min read
• Drug Development

  Ariad Pharmaceuticals, Inc.'s AP24534 Featured in Cancer Cell Publication as a Potential First-in-Class Pan BCR-ABL Inhibitor

  November 2, 2009

   · 

  1 min read